Nuveen
MDLN

Nuveen’s Medline Inc MDLN Stock Holding History

Nuveen’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34M Buy
860,967
+269,750
+46% +$10.9M 0.01% 937
2026
Q1 		$26.3M Sell
591,217
-954,057
-62% -$42.1M 0.01% 985
2025
Q4 		$64.9M Buy
+1,545,274
New +$65.3M 0.02% 534

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nuveen's MDLN Position: Q2 2026 in Review

Nuveen increased its Medline Inc (MDLN) stake by 46% in Q2 2026, buying an estimated $10.9M and bringing the position to 860,967 shares worth $34M. The position accounts for 0.01% of the portfolio, ranked #937.

Nuveen first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $64.9M in Q4 2025. 408 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Nuveen held 860,967 shares of Medline Inc worth $34M as of Q2 2026.
  • Nuveen bought 269,750 Medline Inc shares in Q2 2026, an estimated $10.9M.
  • Medline Inc made up 0.01% of Nuveen's portfolio in Q2 2026, its #937 holding.
  • Nuveen first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • Nuveen's Medline Inc position peaked at $64.9M in Q4 2025.
  • 408 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.